Intracytoplasmic sperm injection — micromanipulation fertilization simulator
Intracytoplasmic Sperm Injection (ICSI) bypasses natural sperm-egg binding by mechanically delivering a single spermatozoon directly into the ooplasm. Success begins long before the needle touches the cell: only fully mature, structurally sound oocytes are injected, and each one must be rotated so its fragile meiotic spindle is never in the path of the pipette.
ICSI can only be performed on oocytes that have completed the first meiotic division and are arrested at metaphase of meiosis II (MII) — the same developmental checkpoint at which oocytes are normally fertilized in vivo. Maturity is judged under a stereo/inverted microscope after cumulus and corona radiata cells are stripped away with hyaluronidase:
• Metaphase II (MII) — first polar body present, no visible germinal vesicle: injectable • Metaphase I (MI) — no polar body, no germinal vesicle: not yet mature, sometimes cultured a few hours for possible extrusion • Germinal vesicle (GV) stage — a visible nucleus, prophase I arrest: immature, not injected
Only MII oocytes are used because injecting an immature oocyte risks activating it prematurely without a functional spindle to complete chromosome segregation, producing an abnormal chromosome complement.
Typically 75–85% of oocytes retrieved after controlled ovarian stimulation are at the MII stage and eligible for ICSI; the remainder are immature (MI/GV) or post-mature/degenerate and are excluded.
The oocyte is immobilized on a blunt, fire-polished holding pipette (outer diameter ~80–120 μm, inner bore ~15–20 μm) using gentle, continuous negative pressure generated by a mineral-oil-filled micrometer syringe. The suction must be firm enough to prevent rotation during injection, yet gentle enough not to rupture the zona or distort the ooplasm.
The holding pipette also serves as the pivot for orientation: rotating the microscope stage or gently repositioning the pipette allows the embryologist to spin the oocyte on its own axis, viewed live at 200–400× magnification, until the polar body is placed precisely at 12 o'clock (or 6 o'clock).
The first polar body is extruded adjacent to the metaphase-II spindle, which holds the oocyte's haploid chromosome set aligned and ready for the second meiotic division. The spindle itself is optically translucent under standard brightfield optics but is reliably co-located with the polar body, typically within a 40–60° arc.
By convention, the injection pipette always approaches at the 3 o'clock position. Placing the polar body at 12 o'clock (or 6 o'clock) — 90° away from the injection site — keeps the spindle apparatus outside the pipette's trajectory. Spindle damage during injection can cause chromosome missegregation, aneuploidy, or failed fertilization, so this orientation step is treated as a mandatory safety checkpoint on every oocyte, every time.
ICSI requires only a single viable spermatozoon per oocyte, which makes it the treatment of choice for severe male-factor infertility — including cases with counts far too low for conventional IVF. The chosen sperm must first be rendered immotile and membrane-compromised before it can be safely aspirated and injected.
Spermatozoa are examined in a viscous polyvinylpyrrolidone (PVP) medium, which slows their swimming enough for careful visual assessment without immobilizing them outright. The embryologist selects a sperm using strict Kruger/Tygerberg morphology criteria: an oval, smooth head (4.0–5.5 μm long, 2.5–3.5 μm wide) with a well-defined acrosome, a normal midpiece, and a single uncoiled tail.
For severe oligoasthenoteratozoospermia or azoospermia, sperm may instead be surgically retrieved (TESE, TESA, PESA, MESA) directly from the testis or epididymis; in these cases even a single motile or twitching cell can be sufficient.
The injection pipette is pressed firmly across the mid-to-distal tail, pinning it against the glass dish bottom, and a brisk backward flick fractures the tail's outer fibrous sheath and axoneme. This single mechanical step accomplishes two goals simultaneously:
• Immobilization — an intact, thrashing flagellum inside the ooplasm would continue beating and could physically damage the spindle or cytoskeleton • Membrane micro-disruption — the crush perforates the plasma membrane, which is believed to help release the sperm-borne oocyte-activating factor (phospholipase C-zeta, PLCζ) into the ooplasm on injection, triggering the calcium oscillations that drive normal fertilization
A sperm that is aspirated without an effective tail crush shows markedly lower fertilization rates — an intact plasma membrane impedes PLCζ release and calcium-oscillation-driven oocyte activation.
The immobilized sperm is drawn tail-first into the injection pipette lumen (5–7 μm inner diameter) using precise negative pressure, so the head sits just inside the bevelled tip, ready to be expelled first on injection. Positioning the sperm tail-first:
• Protects the acrosome-bearing head from mechanical shear against the pipette wall during aspiration • Lets the operator control exactly how much of the sperm — and how little accompanying medium — enters the oocyte • Keeps the head oriented for a clean, minimal-volume deposition once the pipette is inside the ooplasm
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Ejaculated sample | Standard male-factor infertility | Density-gradient or swim-up preparation from fresh/frozen ejaculate | Non-invasive, largest sperm yield |
| PESA | Obstructive azoospermia | Percutaneous epididymal sperm aspiration with a fine needle | Minimally invasive, outpatient |
| MESA | Obstructive azoospermia (repeat cases) | Microsurgical epididymal sperm aspiration under direct vision | High sperm yield, allows cryopreservation |
| TESE / micro-TESE | Non-obstructive azoospermia | Surgical testicular tissue biopsy, mechanical/enzymatic sperm extraction | Only option when spermatogenesis is focal/patchy |
This is the mechanical heart of ICSI: a glass pipette barely wider than a red blood cell must pierce two protective barriers — the tough acellular zona pellucida and the elastic oolemma — without tearing the oocyte apart. Confirming true membrane breach, rather than just indentation, is what separates a successful injection from a failed or degenerated oocyte.
The zona pellucida is a glycoprotein matrix (ZP1, ZP2, ZP3/ZP4) 13–20 μm thick that normally mediates species-specific sperm binding and blocks polyspermy in natural fertilization. In ICSI it is breached mechanically rather than enzymatically:
• The bevelled, sharpened injection pipette tip is driven straight through the zona at the 3 o'clock position under joystick or motorized micromanipulator control • Piezo-assisted ICSI systems instead use rapid micro-vibration pulses to drill through the zona with minimal deforming force, reducing the risk of oocyte distortion • A small plug of zona material is sometimes visibly displaced ahead of the pipette tip just before it breaks through into the perivitelline space
Once inside the perivitelline space, the pipette tip contacts the oolemma — the oocyte's plasma membrane — which is remarkably elastic and initially resists puncture, stretching inward into a visible cone or "tent" as the pipette advances.
A brisk, controlled pulse of negative pressure is applied at this point. This is the critical confirmation step of the entire procedure: a sudden, visible inrush of granular ooplasm into the pipette lumen signals that the oolemma has actually ruptured, rather than merely being pushed ahead of the tip unbroken. Without this positive confirmation, the sperm would be deposited into the perivitelline space rather than the cytoplasm, and fertilization would fail.
Micromanipulators used in ICSI achieve roughly 0.1 μm positioning precision — motion smaller than the wavelength of visible light — enabling the sub-second control needed to tent, rupture, and immediately release oolemma tension without over-penetrating the far side of the oocyte.
Roughly 5–10% of oocytes present an unusually elastic or "hard" oolemma that resists the first rupture attempt even after clear tenting. Repeated puncture attempts increase mechanical trauma and the risk of oocyte degeneration, so embryologists typically limit attempts to two or three per oocyte before either succeeding or abandoning that individual cell to protect the remaining cohort.
With the oolemma confirmed breached, the actual delivery of the spermatozoon takes only a moment — but how gently it is done, and how carefully the pipette retreats afterward, strongly influences whether the oocyte survives the procedure intact.
With the pipette tip confirmed inside the cytoplasm, the sperm — sitting near the bevelled opening after tail-first aspiration — is expelled with the smallest possible volume of surrounding culture medium, typically under 10 picoliters. Injecting excess fluid unnecessarily expands the oocyte volume and dilutes the ooplasm, both of which can reduce developmental competence.
The sperm is placed centrally within the cytoplasm rather than left near the membrane, ensuring it is fully surrounded by the ooplasmic machinery that will decondense its chromatin and form the male pronucleus.
The pipette is retracted slowly along the identical path it entered, rather than at an angle, minimizing shear trauma to the cytoskeleton and cortical cytoplasm. As the tip clears the oolemma, the membrane's intrinsic elasticity allows it to reseal over the puncture site within seconds — aided by rapid local actin cytoskeletal remodeling at the wound site, the same repair mechanism cells use for general membrane injuries.
The zona pellucida track, being a rigid gel matrix rather than a lipid membrane, does not reseal in the same way but remains mechanically stable; the small channel left behind does not compromise the zona's structural integrity or its later role in guiding early embryo cleavage.
Roughly 90–95% of injected mature oocytes survive the ICSI procedure intact; the remainder degenerate — typically visible within minutes as cytoplasmic granulation, blebbing, or frank lysis. Survival is influenced by:
• Injection technique — excessive aspiration/expulsion volume, multiple puncture attempts, or a jagged (rather than smoothly bevelled) pipette tip increase trauma • Oocyte quality — post-mature or previously stressed oocytes have more fragile membranes • Withdrawal speed — abrupt retraction can tear the still-healing membrane before resealing is complete
Surviving, normally fertilizing oocytes are the only ones carried forward to embryo culture and eventual transfer or cryopreservation.
A skilled embryologist can inject a full cohort of 10–15 oocytes in well under an hour, with each individual injection — from pipette entry to withdrawal — typically taking only 5–15 seconds.
Fertilization is never assessed at the moment of injection — it takes until the following morning, 16 to 18 hours later, to know whether the sperm and oocyte genomes have each properly re-organized into visible pronuclei. This single microscopic checkpoint determines which embryos proceed to cleavage-stage or blastocyst culture.
Sperm-borne PLCζ released at injection triggers repetitive intracellular calcium oscillations in the ooplasm — the same activation signal that a fusing sperm delivers in natural fertilization. This calcium signaling drives two parallel events over the following hours:
• Completion of meiosis II — the oocyte's chromosomes segregate one final time, extruding a second polar body and leaving a haploid maternal chromosome set that decondenses into the female pronucleus • Male pronucleus formation — the tightly packaged, disulfide-crosslinked sperm chromatin decondenses, protamines are exchanged for oocyte-supplied histones, and a nuclear envelope re-forms around the paternal chromosomes
Both pronuclei migrate toward the oocyte center and become visible as two distinct, round, translucent structures — each containing several small nucleoli-like precursor bodies — by 16–18 hours post-injection.
The embryologist examines each oocyte under an inverted microscope at this single defined time window, since pronuclei fade and become harder to distinguish as the zygote approaches its first mitotic division:
• 2PN + 2 polar bodies — normal fertilization, proceeds to embryo culture • 1PN — either parthenogenetic activation without sperm contribution, or unsynchronized pronuclear appearance (a repeat check may be warranted); such embryos are generally excluded from transfer • 3PN (or more) — abnormal, typically from failure to extrude the second polar body or retention of an extra maternal/paternal chromosome set, producing a triploid zygote; these are discarded • 0PN — either fertilization failure or oocyte degeneration
ICSI bypasses the zona pellucida's natural block to polyspermy, but the injection itself introduces only one sperm — so the small residual rate of 3PN zygotes in ICSI (roughly 1–3%) mainly reflects meiotic segregation errors rather than multiple sperm entry.
Zygotes confirmed as 2PN proceed to extended embryo culture, with further checkpoints tracking development:
• Day 2–3: cleavage-stage check (ideally 4 cells by day 2, 6–8 cells by day 3, with minimal fragmentation) • Day 5–6: blastocyst formation, graded by expansion, inner cell mass, and trophectoderm quality — roughly 40–50% of 2PN zygotes reach usable blastocyst stage • Selected blastocysts may undergo preimplantation genetic testing (PGT) before a single embryo is transferred or vitrified for later use
Overall, ICSI achieves fertilization rates of 70–80% per mature oocyte injected — comparable to or exceeding conventional IVF insemination — which is why it has become the default insemination method in the majority of IVF cycles worldwide, not only for male-factor infertility but also for cases of prior low or failed fertilization.